NSE filing, NSE: FLYSBS. Summary written from the filing by ALFA Finder's alert engine.
FlySBS Aviation Ltd: key numbers
- Share price
- ₹559.90
- Market cap
- ₹968.8 Cr
- Revenue (annual)
- ₹318.5 Cr
- Net profit (annual)
- ₹60.77 Cr
- P/E (TTM)
- 15.9×Sector 32.6×
- Promoter holding
- 32.47%+0.00% QoQ
- FII holding
- 2.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from FlySBS Aviation Ltd
All →FlySBS Aviation Board Meeting Date
FlySBS Aviation has scheduled a board meeting for 11 November 2026 to consider unaudited half-yearly results for the period ended September 2026. The trading window is not closed.
FlySBS Aviation Other Announcement
FlySBS Aviation has filed a non-applicability intimation for the Corporate Governance Report under Reg 27. The exemption applies as its shares are listed exclusively on the SME Exchange.
FlySBS Aviation Capacity Expansion: ₹13.98 Cr Investment
FlySBS Aviation will induct a Hawker 900XP 9-seater aircraft in October 2026, funded by Rs.13.98 Crore from IPO proceeds. Fleet rises from two to three aircraft.
- Value
- ₹13.98 Cr
- Execution
- October 2026
- fleet capacity (9-seater aircraft)
- 1.0 aircraft
FlySBS Aviation Acquisition
FlySBS Aviation inducted a Hawker 900XP aircraft with nine-passenger seating. The addition aims to expand its operations in business aviation.
- passenger seating capacity
- 9.0 seats
FlySBS Aviation Annual General Meeting
FlySBS Aviation Limited conducted its 6th Annual General Meeting on September 29, 2026. Shareholders adopted financial statements and approved the increase of borrowing powers.
FlySBS Aviation Partnership
FlySBS Aviation signed a long-term Aviation Fuel Supply Agreement with HPCL under IATA Model Terms. The deal secures Jet A-1 fuel access across HPCL's India aviation fuelling network.
- Execution
- Long-term
Other board meeting date announcements
All →Arvaya Healthcare Board Meeting Date
Arvaya Healthcare Ltd intimated a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
Aspire & Innovative Advertising Board Meeting Date
Aspire & Innovative Advertising scheduled a November 14, 2026 board meeting to consider unaudited standalone results for the half year ended September 30, 2026. No results figures are attached yet.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.
Shri Krishna Devcon Board Meeting Date
Shri Krishna Devcon informs BSE of a board meeting on 14 November 2026 to consider quarterly and half-year unaudited results. The trading window stays closed until 48 hours after results are declared.
Cian Healthcare Board Meeting Date
Cian Healthcare intimated that its board will meet on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results.